• Proteasomes: A Novel Approach to Target the Immune System
  • Cognito Therapeutics Secures $105M Series C to Advance At‑Home Alzheimer’s Therapy
  • Aeovian Pharmaceuticals Secures $55M Series B Funding
Apollo Health Ventures - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
HomeApollo Health Ventures
Apollo Health Ventures logo

Apollo Health Ventures

0 followers

About Apollo Health Ventures

Apollo Health Ventures is a transatlantic early‑stage venture capital firm that co‑founds and invests in transformative healthcare companies focused on age‑related diseases and longevity. Leveraging a venture‑lab model, they combine traditional funding with hands‑on venture building to create next‑generation biotech and health‑tech companies across Europe and the United States.

Recent News

Proteasomes: A Novel Approach to Target the Immune System

Recent Deals

Cognito Therapeutics Secures $105M Series C to Advance At‑Home Alzheimer’s Therapy

March 5, 2026

Aeovian Pharmaceuticals Secures $55M Series B Funding

December 16, 2025

Key Team Members

Dr. Alexandra Bause

Co-Founder & Venture Partner

Jan Adams, Ph.D., MBA

Partner

Nils Regge

Co-Founder & General Partner

Dr. Marianne Mertens

Partner

Dr. Ole Mensching

Co-Founder & General Partner

Key Facts

HQ Location

Hamburg, Germany

Founded

2016

Employees

11 - 50

Status

Investor

Investor Type

Venture Investor

Website

https://apollo.vc